AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Original Transcript:\nSITUATION: 25-year-old G1P0 at 12+3 weeks gestation presenting with excessive nausea, vomiting, and suspected molar pregnancy\n\nBACKGROUND: Miss Adams has experienced severe hyperemesis since 8 weeks gestation, significantly worse than typical morning sickness described by friends. She reports vomiting 15-20 times daily, unable to keep down solid food for 2 weeks, and has lost 6kg since pregnancy confirmation. She also noticed vaginal spotting for 3 days, initially light pink but now brown discharge. Her symptoms seem disproportionately severe for gestational age. Last menstrual period was 13 weeks ago, home pregnancy tests have been consistently strongly positive. No previous pregnancies, conceived naturally after 4 months of trying. Family history includes thyroid disease (maternal). She appears significantly dehydrated and has been unable to work for 1 week due to severity of symptoms.\n\nASSESSMENT: Patient appears dehydrated and unwell, with obvious weight loss. Vital signs: BP 108/68 mmHg, HR 102 bpm, temp 36.9°C. Weight 52kg (down from 58kg at GP booking). Thyrotoxic signs present: mild tremor, warm skin, tachycardia. Abdominal examination reveals uterine size larger than expected for dates (approximately 16-week size). Speculum shows brown discharge from cervical os, no active bleeding. Transvaginal ultrasound demonstrates characteristic 'snowstorm' appearance with multiple cystic spaces throughout uterine cavity, no fetal pole visible. Quantitative β-hCG markedly elevated at 186,000 mIU/mL (much higher than expected for gestational age). Thyroid function tests show suppressed TSH <0.1 mU/L, elevated free T4 28 pmol/L indicating gestational thyrotoxicosis. Chest X-ray clear, no evidence of pulmonary metastases.\n\nRECOMMENDATION: Diagnosis of complete hydatidiform mole requiring urgent evacuation. Pre-operative investigations including FBC, coagulation screen, cross-match for 2 units blood. Surgical evacuation arranged urgently via suction curettage under general anesthetic. IV fluid resuscitation commenced. Antiemetics for symptom control. Propranolol considered for thyrotoxicosis symptoms. Post-evacuation histology confirmation and registration with regional trophoblastic screening center mandatory. Serial β-hCG monitoring weekly until negative then monthly for 6 months. Reliable contraception essential during follow-up period. Patient counseled regarding excellent prognosis with appropriate follow-up and monitoring.\n\nCombined Guideline Analyses:\n\n\n=== GUIDELINE 1: Management of Gestational Trophoblastic Disease ===\nHere is the analysis of the clinical note against the provided guideline, with recommendations for improvement:\n\n### Very Important Recommendations\n1. **Additional information needed** - Document whether Anti-D prophylaxis was given (if the patient is Rh-negative).  \n   Reason: The guideline recommends Anti-D prophylaxis following removal of a molar pregnancy to prevent Rh sensitization in future pregnancies.  \n\n2. **Different management plan** - Ensure oxytocic infusion is **not** used prior to completion of surgical evacuation unless significant hemorrhage occurs.  \n   Reason: The guideline advises against oxytocin infusion before completion of removal due to the risk of tissue embolization, unless there is significant bleeding requiring expedited surgical management.  \n\n3. **Improved patient advice** - Explicitly counsel the patient on the need for **reliable contraception** during follow-up and the recommended interval before attempting another pregnancy.  \n   Reason: The guideline emphasizes avoiding pregnancy until hCG levels normalize (usually 6 months for molar pregnancy without GTN, 1 year if chemotherapy was required).  \n\n### Somewhat Important Recommendations  \n1. **Additional information needed** - Confirm whether the patient was referred to a **regional trophoblastic screening center** (mentioned in the note, but ensure documentation of referral completion).  \n   Reason: The guideline mandates registration and follow-up at a GTD center for all molar pregnancies.  \n\n2. **Improved patient advice** - Provide written information on **support groups and GTD resources** for psychological support.  \n   Reason: The guideline highlights the importance of support for women and families affected by GTD.  \n\n3. **Different management plan** - Consider **ultrasound guidance** during suction curettage to minimize perforation risk and ensure complete evacuation.  \n   Reason: The guideline suggests ultrasound guidance may improve safety and completeness of molar pregnancy removal.  \n\n### Less Important Recommendations  \n1. **Additional information needed** - Document whether **chest X-ray findings** were reviewed for possible metastases (already done in the note, but ensure formal reporting).  \n   Reason: The guideline notes that rare cases may present with pulmonary metastases (though this patient’s CXR was clear).  \n\n2. **Improved patient advice** - Advise the patient to report any **new symptoms (e.g., dyspnea, hemoptysis, seizures)** immediately.  \n   Reason: The guideline mentions that metastatic GTN can present with these symptoms, though they are rare.  \n\n### Unimportant Recommendations  \n1. **Additional information needed** - Consider adding a note about **thyroid function monitoring post-evacuation**, as gestational thyrotoxicosis typically resolves after molar removal.  \n   Reason: While not explicitly required by the guideline, it may help in comprehensive follow-up.  \n\n### Summary of Key Missing Elements:\n- **Anti-D prophylaxis** (if applicable)  \n- **Avoidance of pre-evacuation oxytocin** unless hemorrhage occurs  \n- **Explicit contraception counseling**  \n- **Ultrasound guidance during evacuation** (if not already used)  \n\nThe note is **largely compliant** with the guideline but could be strengthened in these areas. Would you like any further refinements?\n\n=== GUIDELINE 2: GP004 Diagnosis and Management of Gestational Trophoblastic Disease (GTD) ===\nHere is the analysis of the clinical note against the provided guideline, with recommendations for improvement:\n\n### Very Important Recommendations\n1. **Additional information needed** - Document whether a P1 form (histological assessment of Products of conception) was completed prior to surgical evacuation, as this is mandatory per the guideline.  \n   Reason: Guideline section 5.3 states this is required for all evacuations to exclude trophoblastic disease.  \n\n2. **Different management plan** - Ensure the surgical evacuation is performed at the PRH site (not Lewes Victoria) as specified in the guideline.  \n   Reason: Guideline section 6.1 specifies the procedure location for suspected molar pregnancies.  \n\n3. **Improved patient advice** - Explicitly document counseling about the prohibition of intrauterine contraceptive devices (IUCDs) until hCG normalizes and the preference for barrier methods.  \n   Reason: Guideline section 8.3 and 8.6 emphasize this contraceptive advice.  \n\n### Somewhat Important Recommendations\n1. **Additional information needed** - Document whether Anti-D prophylaxis was given (though not required for confirmed complete mole, per guideline section 6.7).  \n   Reason: Guideline section 6.6-6.7 clarifies Anti-D requirements based on mole type.  \n\n2. **Improved patient advice** - Include specific counseling about the 1/80 risk of recurrent molar pregnancy and the need for early viability scans in future pregnancies.  \n   Reason: Guideline sections 9.1 and 8.7 highlight these points for patient awareness.  \n\n3. **Different management plan** - Avoid oxytocic infusion prior to evacuation completion unless life-threatening bleeding occurs.  \n   Reason: Guideline section 6.4 advises against routine use of oxytocics.  \n\n### Less Important Recommendations\n1. **Additional information needed** - Note whether the EPU nurse provided the GTD leaflet and confirmed referral to Charing Cross Hospital.  \n   Reason: Guideline section 7.1-7.2 outlines post-diagnosis communication steps.  \n\n2. **Improved patient advice** - Mention the option to continue oral contraception if already started (with caveats).  \n   Reason: Guideline section 8.5 addresses this scenario.  \n\n### Unimportant Recommendations\n1. **Additional information needed** - Consider documenting whether cervical preparation was used immediately prior to evacuation (though not critical if prolonged preparation was avoided).  \n   Reason: Guideline section 6.2 mentions this as safe but not mandatory.  \n\n2. **Improved patient advice** - Reiterate the excellent prognosis (98-100% cure rate) during counseling, though this is already implied in the note.  \n   Reason: Guideline introduction cites this statistic for reassurance.  \n\n### Key Strengths of the Current Note:\n- Aligns well with guideline recommendations for urgent evacuation, serial β-hCG monitoring, and thyrotoxicosis management.  \n- Clearly documents critical features (e.g., ultrasound findings, β-hCG levels, thyroid dysfunction).  \n- Mentions mandatory registration with a trophoblastic screening center.  \n\nThe note is largely compliant but would benefit from explicit documentation of the P1 form, procedural location, and contraceptive counseling to fully adhere to the guideline.\n\n=== GUIDELINE 3: CG13019 Triage of Maternity Patients Guideline ===\nSince the guideline content (CG13019 Triage of Maternity Patients Guideline) is not available for reference, I cannot provide specific recommendations tied to that guideline. However, based on standard clinical practice and general guidelines for molar pregnancy management, I can provide some general recommendations for improvement:\n\n### Very Important Recommendations\n1. [Additional information needed] - Document whether the patient has been screened for trophoblastic disease risk factors (e.g., prior molar pregnancy, maternal age >35 or <20, Asian ethnicity).\n   Reason: Risk factor assessment is critical for prognosis and follow-up planning in molar pregnancies.\n\n2. [Different management plan] - Consider adding methotrexate prophylaxis for high-risk complete moles (based on hCG >100,000 mIU/mL and uterine size > dates).\n   Reason: High-risk moles may benefit from prophylactic chemotherapy to prevent persistent trophoblastic disease.\n\n### Somewhat Important Recommendations\n1. [Improved patient advice] - Provide written information about molar pregnancy and the importance of follow-up, including specific warning signs of complications (persistent bleeding, respiratory symptoms, abdominal pain).\n   Reason: Patient education improves compliance with long-term monitoring requirements.\n\n2. [Additional information needed] - Document whether Rh status was checked and if Rhogam was given if patient is Rh-negative.\n   Reason: Rh sensitization prevention is important after uterine evacuation procedures.\n\n### Less Important Recommendations\n1. [Additional information needed] - Consider adding baseline liver/kidney function tests prior to potential chemotherapy.\n   Reason: Important baseline if patient develops persistent trophoblastic disease requiring treatment.\n\n2. [Improved patient advice] - Discuss fertility implications and optimal timing for future pregnancies.\n   Reason: While prognosis is excellent, patients benefit from clear conception planning guidance.\n\n### Unimportant Recommendations\n1. [Improved patient advice] - Consider providing contact information for support groups for molar pregnancy.\n   Reason: While not medically essential, psychosocial support can be valuable.\n\nWithout access to the specific CG13019 guideline content, I cannot confirm whether these recommendations align with that particular protocol. The note appears comprehensive overall, with appropriate urgent management and follow-up planning for this high-risk molar pregnancy case.\n\n=== GUIDELINE 4: CG21009 Maternity Fluid Management as an In-patient or in Labour ===\nHere is the analysis of the clinical note against the CG21009 Maternity Fluid Management guideline, with recommendations for improvement:\n\n### Very Important Recommendations\n1. **Additional information needed** - Document current serum sodium level and trends\nReason: Guideline requires sodium monitoring for patients with >1500ml positive fluid balance or suspected hyponatremia (Section 9.1). This patient has significant fluid losses/dehydration and is at high risk for electrolyte imbalance.\n\n2. **Different management plan** - Implement formal fluid balance monitoring with hourly intake/output recording\nReason: Guideline states fluid balance monitoring is mandatory for hyperemesis patients (Section 4.0 Indications). Current note doesn't document specific fluid intake/output volumes.\n\n3. **Different management plan** - Consider sodium monitoring pathway given severe dehydration/hyperemesis\nReason: Guideline recommends Peripartum Sodium Monitoring Pathway for patients at risk of hyponatremia (Appendix 2). This patient has multiple risk factors including hyperemesis and significant fluid imbalance.\n\n### Somewhat Important Recommendations\n1. **Improved patient advice** - Counsel patient about appropriate fluid intake (isotonic drinks rather than water)\nReason: Guideline recommends against excessive water intake and suggests isotonic drinks (Section 7.0). Important for post-op recovery and prevention of recurrent hyponatremia.\n\n2. **Additional information needed** - Document urine output volume and characteristics\nReason: Guideline requires measurement and recording of all fluid losses (Section 8.2). Important for assessing degree of dehydration and renal function.\n\n3. **Different management plan** - Consider specific IV fluid regimen with electrolyte monitoring\nReason: Guideline emphasizes careful IV fluid management to prevent hyponatremia (Section 8.2). Current plan mentions IV fluids but doesn't specify type/rate.\n\n### Less Important Recommendations\n1. **Additional information needed** - Document baseline weight for fluid balance calculations\nReason: Guideline recommends accurate weight documentation for fluid management (implied in Section 4.0). Helps assess degree of dehydration.\n\n2. **Improved patient advice** - Provide written information about fluid balance importance\nReason: Guideline states importance of explaining fluid balance to patients (Section 8.1). Would improve patient understanding during recovery.\n\n### Unimportant Recommendations\n1. **Additional information needed** - Consider documenting fluid balance totals on transfer\nReason: Guideline recommends recording cumulative balance before transfers (Section 12.0). Minor point for continuity of care during this urgent case.\n\nThe most critical gaps are the lack of documented sodium levels and formal fluid balance monitoring, which are essential for patient safety given the severe hyperemesis and surgical intervention planned. The guideline emphasizes these elements to prevent hyponatremia complications.\n\n=== GUIDELINE 5: GP010 Termination of Pregnancy ===\n### Very Important Recommendations\n1. **Additional information needed** - Document completion of Form HSA1 (Abortion Act Certificate A) with two signatures as required by law.  \n   Reason: Guideline GP010 Section 5.3 mandates completion of Form HSA1 with two qualified medical practitioners' signatures before proceeding with termination.  \n\n2. **Different management plan** - Consider medical management (mifepristone + misoprostol) as an alternative to surgical evacuation, given the high success rates (>90%) and patient acceptability.  \n   Reason: Guideline GP010 Section 7.6–7.7 recommends offering medical management for pregnancies <14 weeks unless contraindicated, with comparable efficacy to surgical evacuation.  \n\n3. **Additional information needed** - Ensure RhD status is confirmed and anti-D immunoglobulin is administered if the patient is RhD-negative.  \n   Reason: Guideline GP010 Section 5.6 requires anti-D prophylaxis for all non-sensitized RhD-negative women within 72 hours of evacuation.  \n\n### Somewhat Important Recommendations\n1. **Improved patient advice** - Counsel the patient on contraceptive options post-evacuation to prevent pregnancy during follow-up (as serial β-hCG monitoring is required).  \n   Reason: Guideline GP010 Section 8.4 emphasizes contraception counseling to avoid pregnancy during the follow-up period.  \n\n2. **Additional information needed** - Document VTE risk assessment and prophylaxis if indicated.  \n   Reason: Guideline GP010 Section 5.9 mandates VTE risk assessment for all women undergoing termination of pregnancy.  \n\n### Less Important Recommendations\n1. **Improved patient advice** - Provide written and verbal discharge instructions, including signs of complications (e.g., infection, heavy bleeding).  \n   Reason: Guideline GP010 Section 8.6 recommends clear discharge information for patient safety.  \n\n2. **Additional information needed** - Screen for Chlamydia and prescribe antibiotic prophylaxis (doxycycline + metronidazole).  \n   Reason: Guideline GP010 Section 5.7 recommends infection screening and prophylaxis for all termination procedures.  \n\n### Unimportant Recommendations\n1. **Improved patient advice** - Suggest over-the-counter ibuprofen for pain management post-procedure (if no contraindications).  \n   Reason: Guideline GP010 Section 7.19 recommends ibuprofen for pain relief but notes it is optional.  \n\n2. **Additional information needed** - Ensure histology request form (P1 consent for cremation) is completed.  \n   Reason: Guideline GP010 Section 5.3 requires this for legal documentation but does not impact immediate clinical care.  \n\n### Summary of Critical Gaps:\n- **Legal compliance**: Missing Form HSA1 certification.  \n- **Patient safety**: RhD prophylaxis and VTE assessment not explicitly documented.  \n- **Optimal care**: Medical management not discussed as an alternative despite guideline recommendations.  \n\nThese adjustments ensure adherence to protocol while maintaining patient-centered care.\n\nPlease extract and consolidate actionable suggestions from these multiple guideline analyses. Create combined suggestions when multiple guidelines recommend similar interventions, and prioritize suggestions based on clinical importance and consensus across guidelines. For each suggestion, include detailed context with relevant quoted text from the supporting guidelines.",
  "system_prompt": "You are a medical AI assistant that converts multiple clinical guideline analyses into structured, actionable suggestions. You will receive analyses from multiple guidelines and must create a comprehensive set of suggestions that prioritizes the most important recommendations while avoiding redundancy.\n\nYour task is to analyze the provided guideline analyses and extract specific, actionable suggestions that can be presented to the user for acceptance, rejection, or modification.\n\nCRITICAL CLINICAL REASONING REQUIREMENTS:\n- You must first understand the specific clinical scenario and current diagnosis from the transcript\n- Carefully assess whether each potential recommendation is APPROPRIATE and INDICATED for this specific case\n- Apply the fundamental principle: \"Will this investigation or intervention change management or improve patient care in this specific scenario?\"\n- Consider the clinical context: is this an acute emergency, established diagnosis, or uncertain diagnostic situation?\n- Distinguish between situations where additional testing is needed vs. where diagnosis is already established\n- Only recommend interventions that would genuinely improve patient care in THIS specific scenario\n\nMULTI-GUIDELINE PROCESSING PRINCIPLES:\n- Combine and consolidate similar recommendations from different guidelines\n- Prioritize recommendations that appear in multiple guidelines or are emphasized as critical\n- Avoid duplicate suggestions - if multiple guidelines suggest the same thing, create one combined suggestion referencing all relevant guidelines\n- When guidelines conflict, clearly note this and explain the rationale for your recommendation\n- Organize suggestions by clinical priority and relevance to the case\n\nGENERAL CLINICAL APPROPRIATENESS PRINCIPLES:\n- Do NOT suggest diagnostic investigations when the diagnosis is already established through adequate clinical and/or imaging findings\n- Do NOT recommend interventions that conflict with the current evidence-based management plan\n- Do NOT suggest serial monitoring of biomarkers when the clinical picture and imaging provide sufficient diagnostic certainty\n- Consider whether additional investigations would actually change the management approach\n- Evaluate the timing: is this the appropriate point in the clinical course for this intervention?\n- Apply cost-benefit analysis: does the potential benefit justify the intervention in this specific case?\n\nFor each suggestion you identify, return ONLY a valid JSON object with the following structure:\n{\n  \"combinedSuggestions\": [\n    {\n      \"id\": \"1\",\n      \"originalText\": \"text from transcript that needs changing OR description of missing element\",\n      \"suggestedText\": \"proposed replacement text\",\n      \"context\": \"detailed explanation of why this change is suggested, including relevant quoted text from the guidelines in quotation marks, and confirmation that this recommendation is appropriate for the specific clinical scenario\",\n      \"category\": \"addition|modification|deletion|formatting\",\n      \"priority\": \"high|medium|low\",\n      \"sourceGuidelines\": [\"Guideline 1 Name\", \"Guideline 2 Name\"],\n      \"consolidatedFrom\": \"explanation of how this suggestion combines recommendations from multiple guidelines, if applicable\"\n    }\n  ],\n  \"guidelinesSummary\": [\n    {\n      \"guidelineTitle\": \"Guideline Name\",\n      \"keyRecommendations\": \"summary of the most important recommendations from this guideline for this case\",\n      \"relevanceScore\": \"high|medium|low\"\n    }\n  ]\n}\n\nCRITICAL FORMATTING REQUIREMENTS:\n- Return ONLY the JSON object - no markdown code blocks, no explanatory text\n- Do not wrap the JSON in ```json or ``` blocks\n- Start your response directly with { and end with }\n- Use sequential numeric IDs starting from \"1\"\n- Ensure all JSON is properly formatted and valid\n\nImportant guidelines for consolidation:\n- If multiple guidelines recommend the same intervention, create ONE suggestion that references all relevant guidelines\n- Prioritize suggestions that are consistently recommended across multiple guidelines\n- When guidelines provide different specifics for the same general recommendation, include the most comprehensive/specific version\n- If guidelines conflict, choose the most appropriate recommendation for this specific case and explain why\n\nImportant guidelines for context field:\n- Provide detailed explanations including WHY the change is needed AND why it's appropriate for this specific case\n- Include specific quoted text from the relevant guidelines using quotation marks\n- Reference which specific guidelines support this recommendation\n- Explain the clinical rationale behind the suggestion\n- EXPLICITLY state why this recommendation is indicated in this particular clinical scenario\n- Make the context informative and educational",
  "transcript_length": 2465,
  "guidelines_count": 5,
  "guideline_titles": [
    "Management of Gestational Trophoblastic Disease",
    "GP004 Diagnosis and Management of Gestational Trophoblastic Disease (GTD)",
    "CG13019 Triage of Maternity Patients Guideline",
    "CG21009 Maternity Fluid Management as an In-patient or in Labour",
    "GP010 Termination of Pregnancy"
  ]
}

A: {
  "combinedSuggestions": [
    {
      "id": "1",
      "originalText": "Document whether Anti-D prophylaxis was given (if the patient is Rh-negative).",
      "suggestedText": "Confirm Rh status and administer Anti-D prophylaxis if Rh-negative, documenting administration.",
      "context": "Multiple guidelines emphasize the importance of Rh status assessment and Anti-D prophylaxis for Rh-negative patients undergoing molar pregnancy evacuation. Guideline 1 states: 'The guideline recommends Anti-D prophylaxis following removal of a molar pregnancy to prevent Rh sensitization in future pregnancies.' Guideline 5 similarly notes: 'Guideline GP010 Section 5.6 requires anti-D prophylaxis for all non-sensitized RhD-negative women within 72 hours of evacuation.' This is critical for preventing alloimmunization in future pregnancies.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["Management of Gestational Trophoblastic Disease", "GP010 Termination of Pregnancy"],
      "consolidatedFrom": "Combined similar recommendations from Guidelines 1 and 5 regarding Rh status and Anti-D prophylaxis"
    },
    {
      "id": "2",
      "originalText": "Ensure oxytocic infusion is not used prior to completion of surgical evacuation unless significant hemorrhage occurs.",
      "suggestedText": "Avoid oxytocic infusion prior to evacuation completion unless life-threatening hemorrhage occurs.",
      "context": "Both Guideline 1 and Guideline 2 strongly advise against routine use of oxytocics before evacuation completion due to risk of tissue embolization. Guideline 1 states: 'The guideline advises against oxytocin infusion before completion of removal due to the risk of tissue embolization.' Guideline 2 similarly notes: 'Guideline section 6.4 advises against routine use of oxytocics.' This is particularly important given the large uterine size and high hCG levels in this case.",
      "category": "modification",
      "priority": "high",
      "sourceGuidelines": ["Management of Gestational Trophoblastic Disease", "GP004 Diagnosis and Management of Gestational Trophoblastic Disease (GTD)"],
      "consolidatedFrom": "Combined similar recommendations from Guidelines 1 and 2 regarding oxytocic use"
    },
    {
      "id": "3",
      "originalText": "Explicitly counsel the patient on the need for reliable contraception during follow-up.",
      "suggestedText": "Provide detailed contraception counseling including prohibition of IUCDs until hCG normalizes, preference for barrier methods, and recommended interval before next pregnancy (6 months for uncomplicated mole).",
      "context": "Contraception counseling is emphasized across multiple guidelines. Guideline 1 states: 'The guideline emphasizes avoiding pregnancy until hCG levels normalize (usually 6 months for molar pregnancy without GTN).' Guideline 2 adds specific details: 'Guideline section 8.3 and 8.6 emphasize...prohibition of intrauterine contraceptive devices (IUCDs) until hCG normalizes and the preference for barrier methods.' This is critical given the need for serial hCG monitoring and risk of persistent disease.",
      "category": "modification",
      "priority": "high",
      "sourceGuidelines": ["Management of Gestational Trophoblastic Disease", "GP004 Diagnosis and Management of Gestational Trophoblastic Disease (GTD)"],
      "consolidatedFrom": "Combined and expanded contraception recommendations from Guidelines 1 and 2"
    },
    {
      "id": "4",
      "originalText": "Consider ultrasound guidance during suction curettage.",
      "suggestedText": "Use ultrasound guidance during suction curettage to minimize perforation risk and ensure complete evacuation.",
      "context": "Guideline 1 recommends: 'The guideline suggests ultrasound guidance may improve safety and completeness of molar pregnancy removal.' Given the large uterine size (16-week equivalent) and complete mole diagnosis, ultrasound guidance would be particularly beneficial to reduce complications in this case.",
      "category": "addition",
      "priority": "medium",
      "sourceGuidelines": ["Management of Gestational Trophoblastic Disease"],
      "consolidatedFrom": "Single recommendation from Guideline 1"
    },
    {
      "id": "5",
      "originalText": "Document current serum sodium level and trends.",
      "suggestedText": "Implement formal fluid balance monitoring with hourly intake/output recording and check serum electrolytes including sodium.",
      "context": "Guideline 4 emphasizes: 'Guideline requires sodium monitoring for patients with >1500ml positive fluid balance or suspected hyponatremia...fluid balance monitoring is mandatory for hyperemesis patients.' Given this patient's severe hyperemesis with 6kg weight loss and dehydration, these measures are critical for safe management.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["CG21009 Maternity Fluid Management as an In-patient or in Labour"],
      "consolidatedFrom": "Expanded fluid management recommendations from Guideline 4"
    },
    {
      "id": "6",
      "originalText": "Document whether a P1 form was completed prior to surgical evacuation.",
      "suggestedText": "Complete and document P1 form (histological assessment of Products of conception) prior to evacuation.",
      "context": "Guideline 2 states: 'Guideline section 5.3 states this is required for all evacuations to exclude trophoblastic disease.' This is a mandatory legal and clinical requirement for proper diagnosis and follow-up of molar pregnancy.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["GP004 Diagnosis and Management of Gestational Trophoblastic Disease (GTD)"],
      "consolidatedFrom": "Single recommendation from Guideline 2"
    },
    {
      "id": "7",
      "originalText": "Provide written information about molar pregnancy and warning signs.",
      "suggestedText": "Provide written information including: warning signs (persistent bleeding, respiratory symptoms), support resources, and follow-up requirements.",
      "context": "Multiple guidelines emphasize patient education. Guideline 1 notes: 'The guideline highlights the importance of support for women and families affected by GTD.' Guideline 3 adds: 'Patient education improves compliance with long-term monitoring requirements.' This is important for this young patient facing a distressing diagnosis.",
      "category": "addition",
      "priority": "medium",
      "sourceGuidelines": ["Management of Gestational Trophoblastic Disease", "CG13019 Triage of Maternity Patients Guideline"],
      "consolidatedFrom": "Combined patient education recommendations from Guidelines 1 and 3"
    },
    {
      "id": "8",
      "originalText": "Consider methotrexate prophylaxis for high-risk complete moles.",
      "suggestedText": "Consider consulting trophoblastic disease center regarding potential methotrexate prophylaxis given hCG >100,000 and uterine size > dates.",
      "context": "Guideline 3 suggests: 'High-risk moles may benefit from prophylactic chemotherapy to prevent persistent trophoblastic disease.' Given this patient's markedly elevated hCG (186,000) and large uterine size, specialist consultation regarding prophylaxis would be prudent, though not universally recommended.",
      "category": "addition",
      "priority": "medium",
      "sourceGuidelines": ["CG13019 Triage of Maternity Patients Guideline"],
      "consolidatedFrom": "Single recommendation from Guideline 3"
    }
  ],
  "guidelinesSummary": [
    {
      "guidelineTitle": "Management of Gestational Trophoblastic Disease",
      "keyRecommendations": "Anti-D prophylaxis if Rh-negative, avoid pre-evacuation oxytocics, detailed contraception counseling, ultrasound guidance for evacuation, patient support resources",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "GP004 Diagnosis and Management of Gestational Trophoblastic Disease (GTD)",
      "keyRecommendations": "P1 form completion, procedural location specification, IUCD prohibition counseling, oxytocic avoidance",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "CG21009 Maternity Fluid Management as an In-patient or in Labour",
      "keyRecommendations": "Formal fluid balance monitoring, sodium monitoring pathway for hyperemesis",
      "relevanceScore": "medium"
    },
    {
      "guidelineTitle": "GP010 Termination of Pregnancy",
      "keyRecommendations": "Anti-D prophylaxis for Rh-negative, legal documentation requirements",
      "relevanceScore": "medium"
    },
    {
      "guidelineTitle": "CG13019 Triage of Maternity Patients Guideline",
      "keyRecommendations": "Risk factor assessment, potential methotrexate prophylaxis for high-risk moles, patient education",
      "relevanceScore": "medium"
    }
  ]
}

--- Token Usage Report ---
Prompt tokens: 4408
Completion tokens: 1885
Total tokens: 6293
Estimated cost: $0.003146